Caris Life Sciences® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer, today announced that the company will present at the 44th Annual J.P.
Parse Biosciences and Codebreaker Labs partner to apply whole transcriptome single cell profiling and causal genomics at scale: Seattle Monday, December 22, 2025, 17:00 Hrs [IST] ...
Collaboration pairs robust synthetic biology platform with massive scale single cell sequencing to overcome long-standing challenges in variant mapping SEATTLE, December 19, 2025--(BUSINESS ...
Parse Biosciences launches Evercode Whole Blood Fixation to enable easy, high-quality single cell RNA-seq from blood.
The Brighterside of News on MSN
Strange parasitic 'mushroom' plant abandoned photosynthesis and somehow flourished
In the damp understory of forests in Taiwan, mainland Japan, and Okinawa, a plant called Balanophora can fool you at first ...
VANCOUVER, BC, Dec. 31, 2025 /CNW/ -- The precision oncology market surged to $139.4 billion in 2025 and is racing toward $317.5 billion by 2035([1]) , driven by a fundamental shift in cancer ...
Triglia discusses her research at the intersection of genetics, epigenetics, single-cell genomics and computational biology.
The collection of high-quality genomic DNA remains a major barrier in pediatric and neurodevelopmental research, particularly ...
News-Medical.Net on MSN
RNA splicing and processing genes emerge as central drivers of aging across tissues
A new research paper featured as the cover of Volume 17, Issue 12 of Aging-US was published on December 22, 2025, titled "A ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback